EMBECTA CORP. Capital Expenditures
EMBECTA CORP. (EMBC) reported Capital Expenditures of $2.20 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- EMBECTA CORP. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.10M, a 175.00% increase year-over-year.
- EMBECTA CORP. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $500.00K, a 400.00% increase year-over-year.
- EMBECTA CORP. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $600.00K, a 60.00% decline year-over-year.
- EMBECTA CORP. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $7.30M.
- EMBECTA CORP. payments to acquire property, plant, and equipment for fiscal 2025 was $9.30M, a 41.14% decline from fiscal 2024.
- EMBECTA CORP. payments to acquire property, plant, and equipment for fiscal 2024 was $15.80M, a 40.38% decline from fiscal 2023.
- EMBECTA CORP. payments to acquire property, plant, and equipment for fiscal 2023 was $26.50M, a 12.29% increase from fiscal 2022.
- EMBECTA CORP. payments to acquire property, plant, and equipment for fiscal 2022 was $23.60M, a 35.87% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $1.60M derived: sum of 2 quarters · filed 2026-08-07 | $2.20M 10-Q · filed 2026-08-07 | $9.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $1.10M 10-Q · filed 2026-05-05 | $8.40M derived: sum of 3 quarters · filed 2026-05-05 | $8.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $600.00K 10-Q · filed 2026-02-05 | $7.90M derived: sum of 2 quarters · filed 2026-02-05 | $8.30M derived: sum of 3 quarters · filed 2026-08-07 | $8.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $7.70M derived: sum of 2 quarters · filed 2026-08-07 | $7.80M derived: sum of 3 quarters · filed 2026-08-07 | $9.30M 10-K · filed 2025-11-25 |
| 2025-06-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $500.00K derived: sum of 2 quarters · filed 2026-08-07 | $2.00M 10-Q · filed 2026-08-07 | $2.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $1.60M 10-Q · filed 2026-05-05 | $1.60M derived: sum of 3 quarters · filed 2026-05-05 | $11.30M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.50M 10-Q · filed 2026-02-05 | $1.50M derived: sum of 2 quarters · filed 2026-02-05 | $11.20M derived: sum of 3 quarters · filed 2026-02-05 | $14.60M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $9.70M derived: sum of 2 quarters · filed 2025-11-25 | $13.10M derived: sum of 3 quarters · filed 2025-11-25 | $15.80M 10-K · filed 2025-11-25 |
| 2024-06-30 | $9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $13.10M derived: sum of 2 quarters · filed 2025-08-08 | $15.80M 10-Q · filed 2025-08-08 | $25.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | $6.10M 10-Q · filed 2025-05-09 | $15.30M derived: sum of 3 quarters · filed 2025-11-25 | $22.10M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $2.70M 10-Q · filed 2025-02-06 | $11.90M derived: sum of 2 quarters · filed 2025-11-25 | $18.70M derived: sum of 3 quarters · filed 2025-11-25 | $24.50M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $16.00M derived: sum of 2 quarters · filed 2025-11-25 | $21.80M derived: sum of 3 quarters · filed 2025-11-25 | $26.50M 10-K · filed 2025-11-25 |
| 2023-06-30 | $6.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $12.60M derived: sum of 2 quarters · filed 2024-08-09 | $17.30M 10-Q · filed 2024-08-09 | $25.90M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $10.50M 10-Q · filed 2024-05-09 | $19.10M derived: sum of 3 quarters · filed 2024-12-11 | $24.40M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $4.70M 10-Q · filed 2024-02-09 | $13.30M derived: sum of 2 quarters · filed 2024-12-11 | $18.60M derived: sum of 3 quarters · filed 2024-12-11 | $24.00M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $13.90M derived: sum of 2 quarters · filed 2024-12-11 | $19.30M derived: sum of 3 quarters · filed 2024-12-11 | $23.60M 10-K · filed 2024-12-11 |
| 2022-06-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $10.70M derived: sum of 2 quarters · filed 2023-08-08 | $15.00M 10-Q · filed 2023-08-08 | $27.80M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | $5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $9.70M 10-Q · filed 2023-05-12 | $22.50M derived: sum of 3 quarters · filed 2023-11-29 | $29.90M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | $4.30M 10-Q · filed 2023-02-14 | $17.10M derived: sum of 2 quarters · filed 2023-11-29 | $24.50M derived: sum of 3 quarters · filed 2023-11-29 | $29.70M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-09-30 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $20.20M derived: sum of 2 quarters · filed 2023-11-29 | $25.40M derived: sum of 3 quarters · filed 2023-11-29 | $36.80M 10-K · filed 2023-11-29 |
| 2021-06-30 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $12.60M derived: sum of 2 quarters · filed 2022-08-15 | $24.00M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $16.60M 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $11.40M 10-Q · filed 2022-03-16 | |||
| 2020-09-30 | $41.90M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |